logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Liling Zhang

The Affiliated Hospital of Southwest Medical University
H指数:42
被引数:6,555

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study

upfront自体干细胞移植在首次完全缓解期对晚期结外NK/T细胞淋巴瘤的治疗：一项多中心回顾性研究

American Journal of Hematology
IF9.9
2026-07-280
PRE
Shaoxuan Hu; Weiping Liu; Linjun Zhao; Wenrong Huang; Zhenyang Gu; Huiqiang Huang; Liping Su; Hui Zhou; Haisheng Liu; Tao Wu; Liling Zhang; Xia He; Mei Shi; Hua Wang; Xiaopei Wang; Jun Zhu; Yexiong Li; Shunan Qi; Yuqin Song
Mutation Profiling, Efficacy Monitoring, and Prognosis Evaluation Using Circulating Tumor DNA in Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Observational Study

外周血T细胞淋巴瘤中使用循环肿瘤DNA的突变分析，疗效监测和预后评估: 一项前瞻性，多中心，观察性研究

American Journal of Hematology
IF9.9
2026-05-210
OAAI
Zhao Donglu; Song Yuqin; Qin Jiayue; Tong Hongyan; Ding Kaiyang; Cai Qingqing; Huang Huiqiang; Wu Lili; Jing Hongmei; Zhang Liling; Qian Wenbin; Bai Ou; Cao Shanbo; Jin Jie; Zhu Jun; Ma Jun
Total marrow irradiation-based conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A multicenter real-world study

基于全身骨髓照射的异基因造血干细胞移植预处理在血液系统恶性肿瘤患者中的应用：一项多中心真实世界研究

Cell Transplantation
IF3.2
2026-04-170
PRE
Yi Zhang; Ran Zhang; Xiena Cao; Yang Yang; Weiwei Jin; Yu Chen; Liling Zhang; Hui Zeng; Ruowen Wei; Ao Zhang; Hongru Chen; Li Wang; Yang Cao; Weijie Cao; Linghui Xia; Wei Shi
Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone for patients with treatment-naive peripheral T-cell lymphoma: A multicenter, open-label, single-arm, phase 1b trial

盐酸米托蒽醌脂质体联合环磷酰胺、长春新碱和泼尼松用于初治性外周T细胞淋巴瘤患者的治疗方案：一项多中心、开放标签、单臂、期1b临床试验

Cancer
IF5.1
2026-03-210
PRE
Yan Gao MD; Ming Jiang PhD; Xuanye Zhang MD; Lihong Liu MD; Liling Zhang PhD; Yufu Li PhD; Xin Wang PhD; Xiaojing Yan MD; Hui Zhou PhD; Huiqiang Huang MD
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)

二线系统性治疗后外周T细胞淋巴瘤患者中，选择性JAK1抑制剂golidocitinib的多中心维持治疗研究（JACKPOT26）

Blood Cancer Journal
IF11.6
2026-03-170
OAAI
Juying Wei; Qingqing Cai; Liling Zhang; Liqun Zou; Zengjun Li; Keshu Zhou; Huijing Wu; Lihua Qiu; Liping Su; Kaiyang Ding; Hui Zhou; Li Yu; Fei Li; Wenyu Li; Li’e Lin; Qing Xiao; Erhua Wang; Hongmei Jing; Meifang Zheng; Hongyu Zhang; Yuhuan Gao; Da Gao; Lijia Chen; Jie Jin
Survival benefit of adjuvant radiotherapy following asparaginase-based chemotherapy in patients with chemo-responsive advanced-stage extranodal NK/T-cell lymphoma: A multicenter study using the CLCG database

异位NK/T细胞淋巴瘤患者对化疗有反应的晚期阶段中，辅助放疗在基于门冬酰胺酶的化疗后的生存获益：一项使用CLCG数据库的多中心研究

international journal of radiation oncology biology physics
IF0
2025-09-170
PRE
Ke Su; Xiao-Rong Hou; Qiu-Zi Zhong; Xin Liu; Li-Ting Qian; Xue-Ying Qiao; Hua Wang; Yuan Zhu; Jian-Zhong Cao; Jun-Xin Wu; Tao Wu; Su-Yu Zhu; Mei Shi; Hui-Lai Zhang; Xi-Mei Zhang; Hang Su; Yu-Qin Song; Jun Zhu; Yu-Jing Zhang; Hui-Qiang Huang; Ying Wang; Xia He; Li-Ling Zhang; Bao-Lin Qu; Yong Yang; Shu-Lian Wang; Shu-Nan Qi; Ye-Xiong Li
Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study

Tazemetostat（一种EZH2抑制剂）在中国复发性/难治性滤泡性淋巴瘤患者中的有效性和安全性：一项多中心、单臂、Ⅱ期研究

eClinicalMedicine
IF10
2025-08-180
PREAI
Junning Cao; Guangliang Chen; Lihua Qiu; Liling Zhang; Ming Jiang; Ying Cheng; Qiaohua Zhang; Lihong Liu; Ping Li; Yuerong Shuang; Huaqing Wang; Hongwei Xue; Huijing Wu; Meifang Zheng; Keshu Zhou; Zhiming Li; Hongmei Jing; Wei Yang; Zunmin Zhu; Wenyu Li; Jiaxuan Wangwu; Heyu Huang; Qiantao Jia; Dongmei Chen; Songhua Fan; M. Ming Shi; Weiguo Su
A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma

HH2853治疗复发和/或难治性外周T细胞淋巴瘤的多中心、开放标签、单臂、Ib期临床试验

JOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
2025-04-270
OA
Hong, Huangming; Chen, Zegeng; Zhang, Mingzhi; Peng, Zhigang; Shen, Jianzhen; Shuang, Yuerong; Zhou, Hui; Guo, Hongqiang; Huang, He; Li, Fei; Qian, Zhengzi; Liu, Lihong; Wang, Liang; Yang, Wei; Zhang, Liling; He, Pengcheng; Qian, Shen; Li, Fugen; Li, Meng; Lin, Tongyu

研究方向

暂未获取到该数据
H
Hang Su
H 指数:27论文数:269被引数:2,331
X
Xia He
H 指数:57论文数:374被引数:1.1万
Y
Ye‐Xiong Li
H 指数:47论文数:540被引数:1.0万
Y
Yuan Zhu
H 指数:30论文数:164被引数:3,050
H
Huilai Zhang
H 指数:37论文数:375被引数:5,125
B
Baolin Qu
H 指数:20论文数:155被引数:1,369
J
Jun Zhu
H 指数:40论文数:324被引数:7,423
吴
吴涛
H 指数:42论文数:198被引数:6,121
F
Fang Zhu
H 指数:16论文数:64被引数:881
王
王华
H 指数:113论文数:1,639被引数:5.8万